Open company graph database — free web & API
Login

AimePro Corporation

株式会社アイメプロ
Ticker
—
Listed market
—
Country
Japan
Employees (non-consolidated)
—
Related companies
2
§01

Basic information

BASIC
Head office
5th Floor, Sumitomo Shiba Daimon Building, 2-5-5 Shiba Daimon, Minato-ku, Tokyo 105-0012, Japan
Chief executive
Shinichi Keino
Capital
12,000,000 JPY
Employees (non-consolidated)
Employees (consolidated)
Start date
End date
§02

Websites

1 DOMAINS
§03

Business

8
MonitoringData Management / Statistical AnalysisMedical WritingPharmaceutical Affairs ConsultingAuditingProject ManagementStaff DispatchExpert Matching Services
§04

Related companies

2 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
JMDC Inc.
Group
Japan CRO Association
Alliance
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§07

News

24 ARTICLES

Notice of Imepro Head Office RelocationSources

Imepro Co., Ltd. will relocate its head office and begin operations at the new address on May 25, 2026. The former office was at 1-5 Nihonbashi-Kodemmacho, Chuo-ku, Tokyo; the new office is on the fifth floor of Sumitomo Shibadaimon Building, 2-5-5 Shibadaimon, Minato-ku, Tokyo. The main telephone line will be unavailable from 1:00 p.m. on May 22 during the changeover. Please contact the company by mobile phone after that time.

Imepro’s Health and Productivity Initiatives Featured on Tokyo Chamber of Commerce WebsiteSources

Imepro Co., Ltd.’s health and productivity management initiatives have been featured on the official website of the Tokyo Chamber of Commerce and Industry. The article describes measures to promote employee health and improve work-life balance.

Imepro Certified as a 2026 Health and Productivity Management Outstanding OrganizationSources

Imepro Inc. was certified in the Small and Medium-Sized Enterprise category of the 2026 Health and Productivity Management Outstanding Organizations program. Health and productivity management is a strategic approach to employee health management from a business perspective, with the aim of energizing organizations and improving performance. Guided by its mission to advance pharmaceuticals and healthcare, Imepro works daily to maintain and improve the health of its employees and their families.

Imepro Webinar No. 6: GCP Revisions and the Clinical Trial EcosystemSources

Imepro Co., Ltd. will hold a webinar on April 9, 2026, from 4:30 to 5:30 p.m. on preparing to transition clinical trial operations in response to GCP revisions and introducing a single IRB. From a practical perspective, the session will cover national policies on redesigning the clinical trial ecosystem, risk-based operations, and promoting decentralized clinical trials, as well as coordination costs, allocation of responsibilities, and balancing speed with quality. It will draw on experience from Osaka University Hospital. The free webinar is intended for pharmaceutical and medical device companies, CROs, and clinical development professionals.

Imepro Webinar 5: Latest Developments in PPI and ICH Guideline OverviewSources

At a webinar on January 29, 2026, Imepro will discuss the latest developments in patient and public involvement (PPI) and the ICH E6(R3) and E22 guidelines. Topics include the evolution from patient-centered approaches to PPI and the importance of stakeholder engagement and scientifically reflecting patient preferences. The event is free and intended for people in the pharmaceutical and medical device industries.

Imepro Receives Silver Certification as a Health Excellence CompanySources

Imepro Inc. received Health Excellence Company certification and Silver Certification through the health declaration program of the Tokyo Federation of Health Insurance Societies, which it joined in July 2024. Under the declaration, the company commits to working with employees to promote health and establishes requirements such as a 100% health-check participation rate and smoking cessation. Health and productivity management is expected to raise employee health awareness, improve the corporate image, and support recruitment.

Real-World Perspectives on Pediatric Drug Development at the 22nd DIA Japan Annual MeetingSources

An Imepro Inc. employee will present on the realities and future outlook of pediatric drug development in Special Session S20 at the 22nd DIA Japan Annual Meeting on October 20, 2025. The presentation will take place in Room 5 from 4:25 to 5:55 p.m.

Free Clinical Trial Explainer Videos for Children Now AvailableSources

Imepro, a CRO focused on the pediatric field, has begun offering free explainer videos for younger children and older elementary school students who may participate in clinical trials. Based on a common informed consent form (ICF) template, the videos are intended for use by physicians and clinical research coordinators to help children understand and agree to trial participation. Users must agree to the terms of use and submit an application.

Imepro to Exhibit at INTERPHEX Week and Regenerative Medicine EXPO TokyoSources

Imepro Inc. will exhibit at INTERPHEX Week / Regenerative Medicine EXPO Tokyo at Tokyo Big Sight from July 9 to 11, at booth W6-1. Advance registration is required; please register before visiting. See the official website for details.

Im’PRO Expert Matching Service LaunchedSources

In June 2025, Imepro Inc. launched Im’PRO, an expert matching service that registers and introduces experienced specialists, including those in drug development, to help companies address business challenges. Applications from experts are also being accepted.

§08

Public records

GOV
National Tax Agency basic information9010001139448
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
株式会社アイメプロ
Trade name (kana)
アイメプロ
Name in English
Corporation type
301
Address
〒103-0001 東京都中央区日本橋小伝馬町1-5
Postal code
1030001
Prefecture code
13
City code
102
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2022-12-14
Change date
2021-09-22
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
12
Correction type
1
Trade name image ID
Address image ID
Sequence number
2467374
METI gBizINFO9010001139448
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
9010001139448
Trade name
株式会社アイメプロ
Trade name (kana)
アイメプロ
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
東京都港区芝大門2丁目5番5号
Postal code
1050012
Prefecture
東京都
Prefecture code
13
City or district
港区
City code
103
Street address
芝大門2丁目5番5号
Organisation type
301
Processing type
12
Correction type
0
Status
Representative
代表取締役 慶野 晋一
Capital
Employees
Employees (male)
Employees (female)
Business summary
Website URL
Year founded
Business category
Date established
2011-04-11
Unified government qualification - grade
||C|
Unified government qualification - business items
303|304|305|306|308|315
Update date
2026-06-19
Key information
9010001139448
§09

Sources & updates

SOURCES
↑